B
Brickell Biotech Inc
F:VCC2
Brickell Biotech Inc
F:VCC2
Price:
0.1344
EUR
30.61%
Market Cap:
€16m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Brickell Biotech Inc
F:VCC2
|
US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
US |
|
Aurora Labs Ltd
ASX:A3D
|
AU |
|
Shandong Longquan Pipeline Engineering Co Ltd
SZSE:002671
|
CN |
|
PostNL NV
AEX:PNL
|
NL |
|
E
|
Ever Glory United Holdings Ltd
SGX:ZKX
|
SG |
|
Fintech Scion Ltd
OTC:FINR
|
UK |
|
Jiangsu Transimage Technology Co Ltd
SZSE:002866
|
CN |
|
L
|
LithiumBank Resources Corp
XTSX:LBNK
|
CA |
|
Soder Sportfiske AB
F:98Q
|
SE |
|
P
|
Poh Huat Resources Holdings Bhd
KLSE:POHUAT
|
MY |
|
M
|
MDC Holdings Inc
LSE:0JW5
|
US |
|
Olav Thon Eiendomsselskap ASA
OSE:OLT
|
NO |
|
D Market Elektronik Hizmetler ve Ticaret AS
NASDAQ:HEPS
|
TR |
|
S
|
Suryoday Small Finance Bank Ltd
NSE:SURYODAY
|
IN |
|
Roivant Sciences Ltd
F:87S
|
UK |
|
Hanchang Corp
KRX:005110
|
KR |
|
B
|
Bank of Zhengzhou Co Ltd
SZSE:002936
|
CN |
Balance Sheet
Balance Sheet Decomposition
Brickell Biotech Inc
Brickell Biotech Inc
Balance Sheet Decomposition is not available for
Brickell Biotech Inc
Brickell Biotech Inc
Balance Sheet
Brickell Biotech Inc
Brickell Biotech Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
30
|
27
|
9
|
|
| Cash Equivalents |
30
|
27
|
9
|
|
| Short-Term Investments |
0
|
0
|
0
|
|
| Other Current Assets |
3
|
3
|
1
|
|
| Total Current Assets |
34
|
30
|
10
|
|
| PP&E Net |
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
|
| Total Assets |
34
N/A
|
30
-12%
|
10
-65%
|
|
| Liabilities | ||||
| Accounts Payable |
1
|
2
|
1
|
|
| Accrued Liabilities |
5
|
3
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
|
| Total Current Liabilities |
6
|
5
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
|
| Total Liabilities |
6
N/A
|
5
-26%
|
3
-36%
|
|
| Equity | ||||
| Common Stock |
1
|
1
|
0
|
|
| Retained Earnings |
106
|
145
|
166
|
|
| Additional Paid In Capital |
132
|
169
|
174
|
|
| Other Equity |
0
|
0
|
0
|
|
| Total Equity |
27
N/A
|
25
-8%
|
7
-71%
|
|
| Total Liabilities & Equity |
34
N/A
|
30
-12%
|
10
-65%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
1
|
3
|
3
|
|
Switch to:
Switch to:
See Also
Discover More
